Intangible Asset [Abstract] Schedule of the Activity in the Intangible Asset [Abstract] INTANGIBLE ASSET Disclosure of intangible assets [text block] Investment In Financial Assets [Abstract] INVESTMENT IN FINANCIAL ASSETS Disclosure Of Investment Financial Assets Explanatory The disclosure of the investment financial assets. Financial Instruments [Abstract] FINANCIAL INSTRUMENTS Disclosure of detailed information about financial instruments [text block] Basis of presentation of the financial statements Descriptionof Basisofpresentationofthefinancialstatements Explanatory The description of accounting policies for basis of presentation of the financial statements. Equity [Abstract] EQUITY ATTRIBUTABLE TO EQUITY HOLDERS OF THE COMPANY: EQUITY Disclosure of share capital, reserves and other equity interest [text block] Operating Segments [Abstract] OPERATING SEGMENTS Disclosure of entity's operating segments [text block] Transactions and Balances with Related Parties [Abstract] TRANSACTIONS AND BALANCES WITH RELATED PARTIES Disclosure of related party [text block] The operating cycle Description Of Accounting Policy Foroperatingcycle Explanatory The description of the entity's accounting policy changes in operating cycle Explanatory. Consolidated financial statements Description Of Accounting Policy For Consolidatedfinancialstatements The description of the entity's accounting policy changes in Consolidated financial statements. Functional currency and foreign currency Description of accounting policy for foreign currency translation [text block] Business Combinations Description of accounting policy for business combinations [text block] Additional Information to the Items of Profit or Loss [Abstract] ADDITIONAL INFORMATION TO THE ITEMS OF PROFIT OR LOSS Disclosure of additional information [text block] Events After The Reporting Period [Abstract] EVENTS AFTER THE REPORTING PERIOD Disclosure of events after reporting period [text block] Material Accounting Policies [abstract] Convertible Promissory Notes [Abstract] CONVERTIBLE PROMISSORY NOTES Disclosure of debt instruments [text block] Schedule of Fair Value Disclosure Of Fair Value [Table Text Block] Schedule of fair value. Convertible Promissory Notes [Line Items] Aggregate principal amount (in Dollars) Aggregate Principal Amount Represent the amount of aggregate principal amount. Principal amount Principal Amount The amount of principal amount. Purchase price Purchase Prices Purchased price per share. Percentage of purchase price Percentage of gross proceeds Percentage Of Gross Proceeds Percentage of purchase price. Interest rate Borrowings, interest rate Convertible Promissory Notes [Table] Range [axis] Range [domain] Bottom of range [member] Bottom of range [Member] Top of range [member] Top of range [Member] Percentage of warrant coverage Percentage Of Warrant Coverage Percentage of warrant coverage. Number of shares (in Shares) Received common shares (in Shares) Total number of shares issued Beginning Balance Shares issued Ending Balance Total number of shares issued Types of antidilutive instruments [axis] Scenario [Axis] Scenario [Domain] Forecast [Member] Percentage of voting equity interests acquired Number of common shares issued Number of Common Shares Issued The number of common shares issued. Excess investment Excess Investment The amount of excess investment. Payment for patents Payment for Patents The amount of payments made for patents. Total payment on patents Total Payment on Patents The amount of payments made on patents. Discount on payments Discount on Payments The rate discount made on payments. Percentage of milestone payment Percentage of Milestone Payment The rate of milestone payment. Amount of equity funding Amount of Equity Funding to Shareholders The amount of equity funding to shareholders. Estimates on Financing Estimated financial effect, contingent liabilities in business combination Classes of intangible assets other than goodwill [axis] Classes of intangible assets other than goodwill [domain] Estimated useful life Useful life measured as period of time, intangible assets other than goodwill Technology [Member] Technology-based intangible assets [member] Schedule of Total Consideration Paid by the Company to Acquire the Equity Interests [Abstract] Issuance of 56,600,000 common shares Cash transferred Earn out liability - milestone of patent submission Other tangible or intangible assets transferred Earn out liability - milestone of financing Liabilities incurred Total consideration transferred Total consideration transferred Total consideration transferred, acquisition-date fair value Schedule of Allocation of the Purchase Price to the Identifiable Assets Acquired and Liabilities [Abstract] Cash and cash equivalents Cash and cash equivalents recognised as of acquisition date Other receivables Other Receivables Recognised as of Acquisition Date The amount recognised as of the acquisition date for other receivables acquired in a business combination. Technology Technology-based intangible assets recognised as of acquisition date Trade payables Trade and other payables recognised as of acquisition date Categories of related parties [axis] Categories of related parties [domain] Merger Agreement [Member] Merger Agreement Member Classes of ordinary shares [axis] Ordinary shares par value Exercise price per share Par value per share Gain and loss on investments Gains (losses) on disposals of investments Purchase agreement amount (in New Shekels) Purchase Agreement Amount Purchase agreement amount. Cash Cash Price per share (in New Shekels per share) Price Per Share Price per share. Loan amount Debt instruments issued Interest rate Interest Rate Interest rate. Profit loss Net loss Loss Loss Profit (loss) Working Capital Working Capital Represent the amount of working capital. Retained earnings Accumulated deficit Intangible asset at ending Intangible asset at beginning Intangible assets, net Intangible assets other than goodwill Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] Cost [Member] Gross carrying amount [member] Issued and outstanding Issued and Outstanding Amount The amount of issued and outstanding of common stock. Issued and outstanding shares Issued and Outstanding Shares The number of shares issued and outstanding. Rate of issued and outstanding shares Percentage of Issued and Outstanding The rate of issued and outstanding shares. Revaluation gain and loss The amount of reevaluation gain and loss. Clearmind [Member] Clearmind Member Investment in Financial Assets (Details) [Table] Classes of ordinary shares [domain] Initial Public Offering [Member] Initial Public Offering Member AutoMax Shares [Member] Auto Max Shares Member Investment in Financial Assets [Line Items] Disclosure of financial assets [line items] Schedule of Companys Financial Instruments [Line Items] Invested amount Proceeds from issuance of ordinary shares (net of issuance expenses) Gross cash proceeds Proceeds from issuing shares Share capital Share Capital Percentage Share capital percentage. Additional Loan Additional Loan Additional loan. Repayments of current borrowings Repayments of current borrowings Aggregate number of the outstanding ordinary shares Aggregate Number Of Outstanding Ordinary Shares Percentage Aggregate number of the outstanding ordinary shares. Loan repayment percentage Probability Of Loan Repayment Probability of loan repayment. Impairment of the loans Impairment loss recognised in profit or loss, loans and advances, operating Additional loan and accrued interest Additional Loan And Accrued Interest Additional loan and accrued interest. Schedule of the Activity in the Intangible Asset Disclosure of detailed information about intangible assets [text block] Classes of share capital [axis] Classes of share capital [domain] Ordinary Shares [Member] Ordinary Share [Member] Common Shares [Member] Ordinary shares [member] Earn-out liability Earn-out liability Amount of earn-out liability. CliniQuantum Ltd.[Member] Clini Quantum Ltd Member NeuroThera [Member] Neuro Thera Member CliniQ [Member] Subsequent Events [Member] Subsequent Events Member Disclosure of detailed information about intangible assets [table] Schedule of the Activity in the Intangible Asset [Line Items] Disclosure of detailed information about intangible assets [line items] Additions Additions other than through business combinations, intangible assets other than goodwill Schedule of Fair Value Measurement of Assets and Liabilities on Recurring Basis Explanatory Disclosure of Fair Value Measurement of Assets and Liabilities on Recurring Basis Explanatory [Table Text Block] The disclosure of fair value measurement of assets and liabilities on recurring basis explanatory. Carrying amount [member] Miza [Member] Percentage of portfolio and equity Portfolio and Equity Percentage Percentage of portfolio and equity. Shares issued to consultants in respect of exercised Restricted Share Units (“RSUs”) (Note 11d) Shares Issued To Consultants In Respect Of Exercised Restricted Share Units The change in equity shares issued to consultants in respect of exercised restricted share units. Rounding shares Rounding Shares The change in equity resulting from rounding shares. Classes of financial instruments [axis] Classes of financial instruments [domain] March 2021 Series A Warrants [Member] March Two Thousand And Twenty One Series AWarrants Member Schedule Of Additional Information To The Items Of Profit Or Loss Abstract Additional Information to the Items of Profit or Loss - Schedule of Additional Information to the Items of Profit or Loss (Details) [Table] Income Statements Locations [Axis] Income Statements Locations Axis IncomeStatementsLocationsDomain [Domain] Wages and related expenses [Member] Wages And Related Expenses Member Professional and directors’ fees [Member] Professional And Directors Fees Member Deemed issuance listing expenses [Member] Deemed Issuance Listing Expenses Member Schedule Of Balances With Related Parties Abstract Transactions and Balances with Related Parties - Schedule of Balances with Related Parties (Details) [Table] Key management personnel [Member] Key management personnel of entity or parent [member] Other related parties [Member] Other related parties [member] Schedule of Balances with Related Parties [Line Items] Transactions and Balances with Related Parties - Schedule of Balances with Related Parties (Details) [Line Items] Other current assets Total current assets Current assets Current liabilities Total current liabilities Current liabilities Non-current liabilities Total non-current liabilities Non-current liabilities Management fees Key Management Personnel Compensation Management Fees The amount of compensation to key management personnel in the form of management fees. Cost of share-based payment Key management personnel compensation, share-based payment Research and development expenses Transfers of research and development to entity, related party transactions Schedule of Benefits to Key Management Personnel [Abstract] Short-term benefits Key management personnel compensation, short-term employee benefits, operating Online Sales [Member] Online Sales Member Disclosure of operating segments [line items] Operating Segments [Line Items] External External Revenues Amount of external revenue. Total Revenues Revenue Cost of revenues Cost of revenues Cost of sales Research and development expenses Research and development expense Sales, marketing and distribution Sales and marketing expense Types of contracts [axis] Shares acquired Acquired Shares Shares acquired. Accumulated interest Accumulated Interest Accumulated interest. Aggregate investment Aggregate Investment Aggregate investment. Total assets Assets CURRENT LIABILITIES: Current liabilities [abstract] Current maturities of long-term loans Current portion of non-current borrowings Schedule of Issued and Outstanding Share Capital [Abstract] Associates [axis] Associates [domain] Non-adjusting events after reporting period [axis] Non-adjusting events after reporting period [domain] Forecast [Member] Forecast Member Events After The Reporting Period [Line Items] Events After the Reporting Date [Line Items] Types of antidilutive instruments [domain] Pre-Funded Warrants [Member] Prefunded Warrants Member b. General and administrative expenses: CGeneral And Administrative Expenses Abstract General and administrative expenses General and administrative expenses, operating Total financial assets at amortized cost Financial assets at amortised cost Investments in financial assets at fair value Financial assets, at fair value Credit from others Credit From Others The amount of credit of others. Loans Borrowings Lease liability Lease liabilities Total financial and lease liabilities Financial liabilities Equity (Details) [Table] SEPA [Member] SEPAMember Fully ordinary shares issued Number of shares issued and fully paid Ordinary shares granted discount rate Ordinary Shares Granted Discount Rate Ordinary shares granted discount rate. Regulatory, professional and other expenses [Member] Research and preclinical studies [Member] February 2026 warrants [Member] Nexentis shares [Member] Clearmind shares [Member] Nexera shares [Member] Polyrizon Series A warrants [Member] Convertible debentures and promissory note Balance Balance Convertible Debentures and Promissory Note Amount of convertible debentures and promissory note. Xylo [Member] Other reserves Reserve of exchange differences on translation [member] Accumulated deficit Retained earnings [member] Total Parent [member] Issuance of ordinary shares, net of issue expenses Issue Of Share Capital Net Of Issue Expense The amount of issue of share capital, net of issue expenses. Issuance and exercise of warrants Increase (decrease) through exercise of warrants, equity Cost of subsidiaries share-based payment Increase (decrease) through share-based payment transactions, equity Cost of share-based payment Adjustments for share-based payments Impairment of loan Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, loans and advances Finance income, net Adjustments for finance income (cost) Equity losses Adjustments for gain (loss) on disposal of investments in subsidiaries, joint ventures and associates Decrease (increase) in other accounts receivable Adjustments for decrease (increase) in trade and other receivables Decrease (increase) in inventory Adjustments for decrease (increase) in inventories Increase (decrease) in trade payables Adjustments for increase (decrease) in trade accounts payable Increase in other payables Adjustments for increase (decrease) in trade and other payables Increase in related parties Adjustments For Increase In Related Parties Adjustments for increase in related parties. Share capital and premium Share premium Reserve from share-based payment transactions Reserve of share-based payments Warrants Warrant liability Foreign currency translation reserve Amount, ordinary shares Reserve of exchange differences on translation Transactions with non-controlling interests Other equity interest Equity attributable to owners of the Company Equity attributable to owners of parent Non-controlling interests Non-controlling interests Total equity (deficiency) Balance Shareholders’ equity Balance Equity Statement of financial position [abstract] Restricted deposits Current restricted cash and cash equivalents Trade receivables Current trade receivables Other accounts receivable Other current receivables Non-controlling interests Non-controlling interests [member] Components of equity [domain] Statement of changes in equity [line items] NON-CURRENT LIABILITIES Non-current liabilities [abstract] Total liabilities and equity Equity and liabilities Profit or loss [abstract] Gross profit Gross proceeds Gross profit Finance expenses Finance costs Loss before income taxes Profit (loss) before tax Equity holders of the Company Profit (loss), attributable to owners of parent Non-controlling interests Profit (loss), attributable to non-controlling interests Loan to related parties Cash advances and loans made to related parties Net cash provided from (used in) investing activities Cash flows from (used in) investing activities Cash flows from financing activities: Cash flows from (used in) financing activities [abstract] Repayment of lease liability Payments of lease liabilities, classified as financing activities Net cash provided by financing activities Cash flows from (used in) financing activities Increase (decrease) in cash and cash equivalents Increase (decrease) in cash and cash equivalents after effect of exchange rate changes Cash and cash equivalents at the beginning of the period Cash and cash equivalents at the end of the period Cash and cash equivalents Cash and cash equivalents (a) Significant non-cash financing and investing activities: Significant Non Cash Transactions Abstract MATERIAL ACCOUNTING POLICIES Disclosure of changes in accounting policies [text block] Depreciation and amortization Adjustments for depreciation and amortisation expense Other accounts receivables Other Accounts Receivables Other accounts receivables. Decrease (increase) in trade receivables Decrease (Increase) In Trade Receivables Decrease (increase) in trade receivables. Withdrawal of restricted bank deposits Withdrawal of Restricted Bank Deposits Withdrawal of restricted bank deposits. Earn-out liability Earn Out Liability Non Current Earn out liability. Related party Noncurrent To Related Parties Related Parties. Cost of share-based payment Cost of Share-Based Payment Cost of share-based payment. Non-controlling interest Noncontrolling Amount Of Interests Non-controlling interests. General [Abstract] GENERAL Disclosure of general information about financial statements [text block] Losses from remeasurement of investment in financial assets Adjustments For Losses From Remeasurement Of Investment In Financial Assets Adjustments for losses from remeasurement of investment in financial assets to reconcile profit (loss) to net cash flow from (used in) operating activities. Total adjustments to the profit or loss Adjustments to reconcile profit (loss) Working capital adjustments: Adjustments for increase (decrease) in deferred income including contract liabilities [abstract] SIGNIFICANT ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS USED IN THE PREPARATION OF THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS Disclosure of significant judgements and assumptions made in relation to interests in other entities [text block] Significant Accounting Judgments, Estimates and Assumptions Used in the Preparation of the Condensed Interim Consolidated Financial Statements [Abstract] Business Combination [Abstract] Business Combination Disclosure of business combinations [text block] Schedule of Allocation of the Purchase Price to the Identifiable Assets Acquired and Liabilities Disclosure of transactions recognised separately from acquisition of assets and assumption of liabilities in business combination [text block] Schedule of Total Consideration Paid by the Company to Acquire the Equity Interests Disclosure of detailed information about business combination [text block] Disclosure of detailed information about business combination [table] Business combinations [axis] Business combinations [domain] Business Combination [Line Items] Disclosure of detailed information about business combination [line items] Net identifiable assets and liabilities acquired Net identifiable assets acquired (liabilities assumed) Goodwill Goodwill recognised as of acquisition date Non-controlling interest Non-controlling interest in acquiree recognised at acquisition date Schedule of Breakdown of Investment in Financial Assets Disclosure Of Detailed Information about Breakdown of Investment in Financial Assets Explanatory The disclosure of detailed information about breakdown of investment in financial assets. Disclosure of financial assets [table] Classes of financial assets [axis] Classes of financial assets [domain] Investment in Financial Assets Short-term investments Other current financial assets Nexentis [Member] AutoMax [Member] Nexera [Member] Polyrizon [Member] Polyrizon Member Related party payable Related Party Payable Recognised as of Acquisition Date The amount recognised as of the acquisition date for trade and other payables assumed in a business combination. Warrants [Member] Warrants Warrants [member] Warrants exercisable term Warrants Exercisable Term Represent the amount of warrants exercisable term. Schedule of Fair Value [Abstract] Proceeds from issuance of February 2026 Notes Proceeds From Issuance Proceeds from issuance. Warrants [Abstract] WARRANTS [Text Block] WARRANTS Schedule of Warrants Schedule of Warrants [Table Text Block] Schedule of warrants. Other Income [Abstract] OTHER INCOME Disclosure of other operating income [text block] Cash payment Cash Payment Cash payment. Finance expenses Finance Expenses Finance expenses. General (Details) [Table] Cash flows from operating activities Net cash used in operating activities Cash flows from (used in) operating activities Operating term Operating Term Schedule of Financial Assets and Financial Liabilities Disclosure of redesignated financial assets and liabilities [text block] General [Line Items] General (Details) [Line Items] Outstanding shares percentage Outstanding Shares Percentage of outstanding shares. Description of reverse stock split Description Of Reverse Stock Split Description of Reverse Stock Split. Bridge Loan Agreement [Member] Bridge Loan Agreement Member Schedule of Issued and Outstanding Share Capital Disclosure Of Issued And Outstanding Share Capital Disclosure of detailed inforamtion about issued and outstanding share capital. Schedule of Group’s CODM Disclosure of operating segments [text block] Schedule of Balances with Related Parties Related Party Balancetext Block Schedule of Additional Information to the Items of Profit or Loss Disclosure of expenses by nature [text block] Schedule of Transactions with Related Parties Disclosure of transactions between related parties [text block] Schedule of Benefits to Key Management Personnel Disclosure of information about key management personnel [text block] March 2021 Series B Warrants [Member] March Two Thousand And Twenty One Series BWarrants Member Exercise price Exercise price, share options granted Warrants and exercise Warrants And Exercise Purchase sale Sale or issue of treasury shares Commitment amount Commitment Amount Commitment amount. Sale of ordinary shares Sale Of Ordinary Shares Sale of ordinary shares. Share price rate Share Price Rate Share price rate. Schedule of Outstanding Warrants (Details) [Table] Equity - Schedule of Outstanding Warrants (Details) [Table] Exercise Price Exercise Of Warrants The change in equity resulting from exercise of warrants. Exercisable Exercisable Warrant Shares of exercisable warrant. Schedule of Additional Information to the Items of Profit or Loss [Line Items] a. Research and development expenses: AResearch And Development Expenses Abstract ASSETS Assets [abstract] CURRENT ASSETS: Current assets [abstract] Types of contracts [domain] Cooperation agreement amount Cooperation Agreement Amount Cooperation Agreement amount. Licensee issue price Licensee Issue Price The amount of licensee, reflecting an issue. Cover [Abstract] Document Type Entity Central Index Key Document Fiscal Year Focus Document Fiscal Period Focus Entity File Number Entity Registrant Name Amendment Flag Document Period End Date Current Fiscal Year End Date Lease liability Current lease liabilities Net Balance [Member] Brand [Member] IP Portfolio [Member] Excess Purchase Price [Member] Management Fees The amount of management fees. Financial Assets: Financial Assets Financial liabilities: License Agreement [Member] Third Party [Member] Licensee Common Warrants [Member] Cooperation Agreement [Member] Securities Purchase Agreement [Member] Securities Purchase Agreements [Member] Securities Purchase Agreements Member Equity [Line Items] Purchase price per share Purchase Price Per Share The purchase price is the price an investor pays for an investment, and the price becomes the investor's cost basis for calculating gain or loss when selling the investment. Segment consolidation items [domain] Amount of gross proceeds Gross Proceeds Shares Amount of gross proceeds of shares. Shares Price Share price. Additional issuance of Ordinary Shares [Member] Events After the Reporting Date (Details) [Table] Aggregate consideration Consideration paid (received) Gross proceeds Proceeds from issue of ordinary shares Percentage of shares issued and outstanding Percentage Of Held Issued And Outstanding Share Capital Percentage of held issued and outstanding share capital. Schedule Of Group SCodm Abstract Operating Segments - Schedule of Group’s CODM (Details) [Table] Segments [axis] Segments [domain] Drug Development [Member] Drug Development Member Loss on impairment of loans Impairment loss recognised in profit or loss, intangible assets other than goodwill Other income, net Other income Other income Segments’ operating loss Impairment loss recognised in other comprehensive income Share-based payment [Member] Share Based Payment Member Clinical studies [Member] Clinical Studies Member Chemistry and formulations [Member] Chemistry And Formulations Member Business development expenses [Member] Business Development Expenses Member Regulatory expenses [Member] Regulatory Expenses Member Office maintenance, rent and other expenses [Member] Office Maintenance Rent And Other Expenses Member Investor relations and business expenses [Member] Investor Relations And Business Expenses Member Finance expense, net Interest income (expense), operating Segment assets Other assets Segment liabilities Other liabilities Schedule of Transactions with Related Parties [Abstract] January 2024 SEPA Agreement [Member] January2024 Standby Equity Purchase Agreement Member Description of factors used to identify entity's reportable segments Description of factors used to identify entity's reportable segments Reportable segment Reportable Segment Reportable segment. Transactions and Balances with Related Parties (Details) [Table] Nexera [Member] Nexera Technologies Ltd Member Transactions and Balances with Related Parties [Line Items] Acquired ordinary shares (in Shares) Acquired Ordinary Shares The number of shares acquired. Aggregate value Aggregate Values The amount of aggregate value. Operating Segments (Details) [Table] May 2022 Warrants [Member] May Two Thousand And Twenty Two Warrants Member Schedule of Outstanding Warrants [Line Items] Warrant Term Warrants Expire Date Warrants expire date. CliniQ Transaction [Member] Issuance of share in respect of January 2026 financing round (Note 11(f)) Issuance of share in respect of January 2026 financing round The number of issuance of share in respect of January 2026 financing round. January 2026 Financing Round [Member] May 2022 warrants [Member] Quantum Technology [Member] Accumulated Amortization and Impairment Charges [Member] Current maturities of long-term loan Current Maturities Of Long-Term Loan Current maturities of long-term loan. Company’s share of losses of company accounted for at equity, net Equity losses of an associate Share of profit (loss) of associates and joint ventures accounted for using equity method, investing Issuance of share capital – in respect of January 2024 SEPA (Note 11(e)) Issuance Of Share Capital In Respect SEPA Number of issuance of share capital – in respect of January 2024 SEPA. Schedule Of Outstanding Warrants Abstract Schedule Of Financial Assets And Financial Liabilities Abstract Cash, cash equivalents and restricted deposits Restricted cash and cash equivalents Other receivables Other receivables Related parties Non-current receivables due from related parties Schedule of Companys Financial Instruments [Abstract] Financial Instruments - Schedule of Company's Financial Instruments (Details) [Table] Levels of fair value hierarchy [axis] Levels of fair value hierarchy [domain] Level 1 [Member] Level 1 of fair value hierarchy [member] Level 2 [Member] Level 2 of fair value hierarchy [member] Level 3 [Member] Level 3 of fair value hierarchy [member] Document Information [Table] Document Information [Line Items] Operating segments [member] Segment consolidation items [axis] Basic loss per ordinary share attributable to equity holders of the Company (in Dollars per share) Basic earnings (loss) per share Diluted loss per ordinary share attributable to equity holders of the Company (in Dollars per share) (in Dollars per share) Diluted earnings (loss) per share Consolidated Statements Of Changes In Equity Abstract Statement of changes in equity [table] Components of equity [axis] Share capital and premium Share premium [member] Reserve from share-based payment transactions Reserve of share-based payments [member] Transactions with non-controlling interests Other equity interest [member] Statement of cash flows [abstract] Cash flows from operating activities: Cash flows from (used in) operating activities [abstract] Adjustments to the profit or loss items: Adjustments to reconcile operating profit (loss) [abstract] Warrants Amount of warrants. Earn-out liability – current portion Earn-Out Liability – Current Portion Amount of earn-out liability – current portion. Loss on impairment of loans Loss on impairment of loans Amount of loss on impairment of loans. Recognition of conversion feature in convertible debenture Increase Decrease Through Recognition of Conversion Feature in Convertible Debent Represents the amount of recognition of conversion feature in convertible debenture. Issuance of ordinary shares, net of issue expenses Issue of equity Transaction with non-controlling interests Amount of transaction with non-controlling interests. Purchase of intangible assets in exchange of issuance of pre-funded warrants Amount of purchase of intangible assets in exchange of issuance of pre-funded warrants. Net cash from consolidation of CliniQuantum Net cash from consolidation of CliniQuantum Amount of net cash from consolidation of CliniQuantum. Consolidation of CliniQuantum Consolidation of CliniQuantum [Abstract] Excess purchase price Amount of excess purchase price. Trade payables Current trade payables Capital reserve from transactions with non-controlling interest Capital reserve from transactions with non-controlling interest Amount of capital reserve from transactions with non-controlling interest. Cash received as consideration for deemed issuance of shares by a subsidiary Cash Received As Consideration For Deemed Issuance Of Shares By ASubsidiary Cash received as consideration for deemed issuance of shares by a subsidiary. Investment in an associate accounted for under the equity method Purchase of investments other than investments accounted for using equity method Proceeds from issuance of convertible debentures and promissory note Proceeds from issue of bonds, notes and debentures Earn-out liability Earn-out liabilities The amount of Earn-out liability Attributable To [Abstract] Net loss and total comprehensive loss Total comprehensive income Investment in an associate accounted for using the equity method Investments accounted for using equity method Investments in financial assets Other non-current financial assets Property and equipment, net Property, plant and equipment Total non-current assets Non-current assets LIABILITIES AND EQUITY Equity and liabilities [abstract] Trade payables Trade payables Other payables Trade and other current payables Related parties Current payables to related parties Accrued legal contingency Accrued Legal Contingency Current Amount of accrued legal contingency. Operating loss Profit (loss) from operating activities Finance income Finance income Cash flows from investing activities: Cash flows from (used in) investing activities [abstract] Current maturities of long-term loan Long-term deposits Loans to related parties Current receivables due from related parties Inventory Current inventories NON-CURRENT ASSETS: Non-current assets [abstract] Related party Non-current payables to related parties Working capital Adjustments to reconcile profit (loss) other than changes in working capital